CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $196,000 | -51.8% | 40,070 | +14.7% | 0.01% | -73.5% |
| Q2 2021 | $407,000 | +31.7% | 34,935 | +37.9% | 0.03% | +21.4% |
| Q1 2021 | $309,000 | +42.4% | 25,334 | +46.2% | 0.03% | +21.7% |
| Q4 2020 | $217,000 | +1.4% | 17,332 | +21.9% | 0.02% | +64.3% |
| Q3 2020 | $214,000 | -46.1% | 14,222 | -12.2% | 0.01% | -50.0% |
| Q2 2020 | $397,000 | +128.2% | 16,193 | +31.8% | 0.03% | +115.4% |
| Q1 2020 | $174,000 | – | 12,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |